Corindus Vascular Robotics Company Profile (NYSEMKT:CVRS)

About Corindus Vascular Robotics (NYSEMKT:CVRS)

Corindus Vascular Robotics logoCorindus Vascular Robotics, Inc. is engaged in robotic-assisted vascular interventions. The Company's CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System it brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. It operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NYSEMKT:CVRS
  • CUSIP: N/A
  • Web: www.corindus.com/
Capitalization:
  • Market Cap: $234.12 million
  • Outstanding Shares: 187,296,000
Average Prices:
  • 50 Day Moving Avg: $1.58
  • 200 Day Moving Avg: $1.50
  • 52 Week Range: $0.40 - $2.25
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.58
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $4.26 million
  • Price / Sales: 54.96
  • Book Value: $0.17 per share
  • Price / Book: 7.35
Profitability:
  • EBITDA: ($34,710,000.00)
  • Net Margins: -372.63%
  • Return on Equity: -94.27%
  • Return on Assets: -75.51%
Misc:
  • Average Volume: 530,367 shs.
  • Beta: 0.89
  • Short Ratio: 16.95
 

Frequently Asked Questions for Corindus Vascular Robotics (NYSEMKT:CVRS)

What is Corindus Vascular Robotics' stock symbol?

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "CVRS."

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEMKT:CVRS) posted its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.04) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.01. The company had revenue of $2.26 million for the quarter, compared to the consensus estimate of $3.10 million. Corindus Vascular Robotics had a negative net margin of 372.63% and a negative return on equity of 94.27%. View Corindus Vascular Robotics' Earnings History.

Where is Corindus Vascular Robotics' stock going? Where will Corindus Vascular Robotics' stock price be in 2017?

2 brokers have issued 12-month price targets for Corindus Vascular Robotics' stock. Their predictions range from $3.00 to $3.00. On average, they expect Corindus Vascular Robotics' share price to reach $3.00 in the next year. View Analyst Ratings for Corindus Vascular Robotics.

Who are some of Corindus Vascular Robotics' key competitors?

Who are Corindus Vascular Robotics' key executives?

Corindus Vascular Robotics' management team includes the folowing people:

  • Jeffrey C. Lightcap, Independent Chairman of the Board
  • Mark J. Toland, President, Chief Executive Officer, Director
  • David W. Long, Chief Financial Officer, Senior Vice President, Treasurer, Secretary
  • John K. Bakewell, Director
  • Louis A Cannon M.D., Director
  • Gerard Winkels, Director
  • Hillel Bachrach, Independent Director
  • Jeffrey Gold, Independent Director

How do I buy Corindus Vascular Robotics stock?

Shares of Corindus Vascular Robotics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Corindus Vascular Robotics' stock price today?

One share of Corindus Vascular Robotics stock can currently be purchased for approximately $1.25.


MarketBeat Community Rating for Corindus Vascular Robotics (NYSEMKT CVRS)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  115 (Vote Outperform)
Underperform Votes:  177 (Vote Underperform)
Total Votes:  292
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Corindus Vascular Robotics (NYSEMKT:CVRS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00
Consensus Price Target History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Price Target History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Analysts' Ratings History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Show:
DateFirmActionRatingPrice TargetDetails
8/9/2017Cowen and CompanySet Price TargetBuy$3.00View Rating Details
5/15/2017B. RileyReiterated RatingBuy$3.00View Rating Details
4/20/2016Sterne Agee CRTReiterated RatingBuy$3.00View Rating Details
1/19/2016Stifel NicolausLower Price TargetBuy$6.00 -> $4.00View Rating Details
(Data available from 10/18/2015 forward)

Earnings

Earnings History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Earnings by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Earnings History by Quarter for Corindus Vascular Robotics (NYSEMKT CVRS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2017Q2 2017($0.05)($0.04)$3.10 million$2.26 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.05)($0.07)$1.59 million$0.78 millionViewListenView Earnings Details
3/15/2017Q4 2016($0.07)($0.08)$0.73 million$0.54 millionViewN/AView Earnings Details
11/8/2016Q316($0.06)($0.07)$1.27 million$0.69 millionViewListenView Earnings Details
3/8/2016Q415($0.05)($0.06)$0.62 million$0.83 millionViewN/AView Earnings Details
11/12/2015Q315($0.06)($0.06)$0.70 million$0.21 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Corindus Vascular Robotics (NYSEMKT:CVRS)
Current Year EPS Consensus Estimate: $-0.21 EPS
Next Year EPS Consensus Estimate: $-0.19 EPS

Dividends

Dividend History for Corindus Vascular Robotics (NYSEMKT:CVRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Corindus Vascular Robotics (NYSEMKT:CVRS)
Insider Trades by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Institutional Ownership by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Insider Trades by Quarter for Corindus Vascular Robotics (NYSEMKT:CVRS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/11/2017Philips Nv KoninklijkeMajor ShareholderSell3,334,586$1.50$5,001,879.00View SEC Filing  
3/22/2017Louis A CannonDirectorBuy27,000$1.30$35,100.00View SEC Filing  
2/28/2017Healthcor Management, L.P.Major ShareholderBuy7,557,436$0.66$4,987,907.76View SEC Filing  
11/25/2016Jeffrey GoldDirectorBuy10,000$0.76$7,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Corindus Vascular Robotics (NYSEMKT:CVRS)
Latest Headlines for Corindus Vascular Robotics (NYSEMKT:CVRS)
Source:
DateHeadline
americanbankingnews.com logoInsider Selling: Corindus Vascular Robotics Inc (CVRS) Major Shareholder Sells 3,334,586 Shares of Stock
www.americanbankingnews.com - October 13 at 7:20 PM
americanbankingnews.com logoCorindus Vascular Robotics Inc (CVRS) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - October 10 at 8:22 PM
businesswire.com logoCorindus Announces Opening of First International Robotic Training Center
www.businesswire.com - September 27 at 6:52 PM
finance.yahoo.com logoCorindus Announces First Patient Enrolled in PRECISION GRX Registry
finance.yahoo.com - September 12 at 6:22 PM
finance.yahoo.com logoCorindus Vascular Robotics, Inc. breached its 50 day moving average in a Bullish Manner : CVRS-US : August 25, 2017
finance.yahoo.com - August 25 at 7:14 PM
finance.yahoo.com logoETFs with exposure to Corindus Vascular Robotics, Inc. : August 25, 2017
finance.yahoo.com - August 25 at 7:14 PM
finance.yahoo.com logoCorindus Vascular Robotics, Inc. :CVRS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 6:05 PM
finance.yahoo.com logoCorindus Vascular Robotics, Inc. breached its 50 day moving average in a Bearish Manner : CVRS-US : August 10, 2017
finance.yahoo.com - August 10 at 6:56 PM
americanbankingnews.com logoCorindus Vascular Robotics Inc (NYSEMKT:CVRS) Issues Earnings Results
www.americanbankingnews.com - August 9 at 6:24 PM
finance.yahoo.com logoEdited Transcript of CVRS earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 9 at 5:53 PM
reuters.com logoBRIEF-Corindus Vascular Robotics Q2 ‍loss per share $0.04
www.reuters.com - August 9 at 3:27 AM
finance.yahoo.com logoCorindus Vascular reports 2Q loss
finance.yahoo.com - August 8 at 10:25 PM
seekingalpha.com logoCorindus Vascular Robotics beats by $0.01, misses on revenue
seekingalpha.com - August 8 at 5:24 PM
finance.yahoo.com logoJohn K. Bakewell Joins Corindus Vascular Robotics Board of Directors
finance.yahoo.com - August 8 at 5:24 PM
finance.yahoo.com logoCorindus Vascular Robotics Reports Second Quarter 2017 Results
finance.yahoo.com - August 8 at 5:24 PM
finance.yahoo.com logoETFs with exposure to Corindus Vascular Robotics, Inc. : August 1, 2017
finance.yahoo.com - August 1 at 6:21 PM
finance.yahoo.com logoCorindus Vascular Robotics to Report Second Quarter 2017 Financial Results on August 8, 2017
finance.yahoo.com - July 25 at 5:40 PM
finance.yahoo.com logoCorindus Vascular Robotics to Report Second Quarter 2017 Financial Results on August 8, 2017
finance.yahoo.com - July 25 at 5:40 PM
finance.yahoo.com logoEdited Transcript of CVRS earnings conference call or presentation 9-May-17 8:30pm GMT
finance.yahoo.com - July 24 at 5:25 PM
finance.yahoo.com logoETFs with exposure to Corindus Vascular Robotics, Inc. : July 6, 2017
finance.yahoo.com - July 6 at 6:55 PM
News IconBRIEF-Corindus Vascular Robotics offering and resale by selling stockholders of 68.1 mln shares
www.businessinsider.com - April 18 at 12:10 PM
businesswire.com logoCorindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath ® GRX System
www.businesswire.com - March 31 at 9:58 PM
finance.yahoo.com logoCorindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath® GRX System
au.finance.yahoo.com - March 31 at 4:43 PM
seekingalpha.com logoCorindus Vascular Robotics' (CVRS) CEO Mark Toland on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 16 at 3:05 AM
nasdaq.com logoCorindus Vascular Robotics (CVRS) Jumps: Stock Gains 19.5% - Nasdaq
www.nasdaq.com - March 15 at 10:03 PM
us.rd.yahoo.com logoCorindus Vascular Robotics Reports Fourth Quarter and Full Year 2016 Results
us.rd.yahoo.com - March 15 at 5:02 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
us.rd.yahoo.com - March 15 at 5:02 PM
seekingalpha.com logoCorindus Vascular Robotics teams up with WakeMed Health to develop national center excellence on robotic-assisted PCI; shares ahead 13% premarket
seekingalpha.com - March 15 at 9:59 AM
biz.yahoo.com logoQ4 2016 Corindus Vascular Robotics Inc Earnings Release - After Market Close
biz.yahoo.com - March 15 at 9:59 AM
reuters.com logoBRIEF-Hudson Executive Capital reports 6.1 pct stake in Corindus Vascular Robotics
www.reuters.com - March 10 at 5:41 PM
seekingalpha.com logoCorindus Vascular Robotics (CVRS) Presents At Cowen and Company 37th Annual Health Care Conference
seekingalpha.com - March 8 at 5:22 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - March 8 at 5:22 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of
biz.yahoo.com - March 1 at 6:16 PM
us.rd.yahoo.com logoCorindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath® GRX System in Japan
us.rd.yahoo.com - February 16 at 1:37 PM
streetinsider.com logoCorindus Vascular Robotics (CVRS) Enters Strategic Distribution Partnership with MC Healthcare Group
www.streetinsider.com - February 16 at 1:37 PM
businesswire.com logoCorindus Vascular Robotics Announces Strategic Distribution Partnership with MC Healthcare Group Granting Exclusive Rights to Distribute the CorPath ® GRX System in Japan
www.businesswire.com - February 16 at 1:37 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - February 16 at 1:37 PM
us.rd.yahoo.com logoCorindus Vascular Robotics Announces First Commercial Procedures Performed Using CorPath® GRX System
us.rd.yahoo.com - February 10 at 4:59 PM
us.rd.yahoo.com logo6:46 am Corindus Vascular Robotics announces that the first commercial procedures have been performed using its CorPath GRX System
us.rd.yahoo.com - February 10 at 4:59 PM
reuters.com logoBRIEF-Corindus Vascular Robotics sees FY 2017 revenue $13 mln-$15 mln
www.reuters.com - January 17 at 5:29 PM
biz.yahoo.com logoCORINDUS VASCULAR ROBOTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - January 17 at 5:29 PM
businesswire.com logoCorindus Vascular Robotics to Present at Upcoming Investor Conferences - Business Wire (press release)
www.businesswire.com - November 3 at 3:59 PM

Social

Chart

Corindus Vascular Robotics (CVRS) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.